华恒生物
(688639)
| 流通市值：46.92亿 | | | 总市值：46.92亿 |
| 流通股本：2.50亿 | | | 总股本：2.50亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 549,705,328.7 | 446,179,600.53 | 284,122,206.43 | 492,952,452.97 |
| 应收票据及应收账款 | 405,603,354.53 | 377,847,673.82 | 391,530,619.12 | 396,453,589.45 |
| 其中：应收票据 | 124,737,179.5 | 113,255,596.93 | 120,285,252.28 | 128,569,439.34 |
| 应收账款 | 280,866,175.03 | 264,592,076.89 | 271,245,366.84 | 267,884,150.11 |
| 应收款项融资 | 12,237,253.85 | 19,203,659.8 | 25,244,452.19 | 19,443,895.55 |
| 预付款项 | 66,592,480.07 | 79,169,893.36 | 47,962,533.79 | 81,156,503.44 |
| 其他应收款合计 | 18,873,119.6 | 14,723,438.97 | 17,446,725.25 | 12,400,075.3 |
| 存货 | 648,487,832.15 | 627,744,841.44 | 532,126,830.56 | 503,592,135.11 |
| 其他流动资产 | 105,639,107.12 | 167,345,192.69 | 165,649,730.89 | 148,264,447.83 |
| 流动资产合计 | 1,807,138,476.02 | 1,732,214,300.61 | 1,464,083,098.23 | 1,654,263,099.65 |
| 非流动资产: | | | | |
| 长期股权投资 | 4,658,359.5 | 4,987,977.37 | 5,054,377.87 | 5,225,092.91 |
| 其他非流动金融资产 | 118,568,134.31 | 119,400,033.33 | 119,400,033.33 | 116,600,033.33 |
| 固定资产 | 2,571,152,096.43 | 2,623,502,389.14 | 2,651,264,903.41 | 2,279,888,780.57 |
| 在建工程 | 1,280,010,445.52 | 1,204,141,840.49 | 1,192,386,961.67 | 1,253,293,352.17 |
| 无形资产 | 147,161,928.71 | 148,578,515.81 | 150,044,791.62 | 150,955,976.36 |
| 长期待摊费用 | 16,476,242.22 | 15,112,093.65 | 13,642,958.02 | 13,386,353.22 |
| 递延所得税资产 | 133,490,410.31 | 128,086,080.09 | 145,296,844.94 | 126,897,597.59 |
| 其他非流动资产 | 53,073,054.04 | 49,891,101.93 | 33,507,510.36 | 71,154,995.62 |
| 非流动资产合计 | 4,324,590,671.04 | 4,293,700,031.81 | 4,310,598,381.22 | 4,017,402,181.77 |
| 资产总计 | 6,131,729,147.06 | 6,025,914,332.42 | 5,774,681,479.45 | 5,671,665,281.42 |
| 流动负债: | | | | |
| 短期借款 | 263,060,262.1 | 221,093,043.89 | 123,381,386.79 | 135,575,029.15 |
| 衍生金融负债 | 265,832.95 | 205,733.92 | - | 104,550 |
| 应付票据及应付账款 | 557,592,395.47 | 616,712,737.73 | 712,680,474.72 | 538,280,119.08 |
| 应付账款 | 557,592,395.47 | 616,712,737.73 | 712,680,474.72 | 538,280,119.08 |
| 合同负债 | 27,155,293.18 | 32,243,359.93 | 16,998,506.07 | 37,335,749.17 |
| 应付职工薪酬 | 34,672,989.93 | 29,457,539.44 | 49,112,998.47 | 38,888,138.39 |
| 应交税费 | 10,875,619.29 | 11,914,782.4 | 7,566,940.1 | 14,191,541.66 |
| 其他应付款合计 | 20,788,049.34 | 22,969,686.85 | 23,672,427.86 | 25,918,208.29 |
| 一年内到期的非流动负债 | 466,555,374.35 | 421,164,072.26 | 363,031,639.1 | 308,190,795.3 |
| 其他流动负债 | 101,493,536.28 | 72,018,960.8 | 42,877,768.86 | 46,684,161.28 |
| 流动负债合计 | 1,482,459,352.89 | 1,427,779,917.22 | 1,339,322,141.97 | 1,145,168,292.32 |
| 非流动负债: | | | | |
| 长期借款 | 1,772,180,512.98 | 1,725,051,609.56 | 1,572,426,984.86 | 1,648,390,496.9 |
| 递延收益 | 88,878,926.84 | 91,814,267.29 | 94,749,607.75 | 84,909,292.56 |
| 递延所得税负债 | 109,867,472.02 | 112,415,879.35 | 136,322,958.25 | 125,495,523.78 |
| 非流动负债合计 | 1,970,926,911.84 | 1,929,281,756.2 | 1,803,499,550.86 | 1,858,795,313.24 |
| 负债合计 | 3,453,386,264.73 | 3,357,061,673.42 | 3,142,821,692.83 | 3,003,963,605.56 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 250,115,693 | 250,115,693 | 250,115,693 | 250,115,693 |
| 资本公积 | 1,217,719,545.95 | 1,217,719,545.95 | 1,217,719,545.95 | 1,217,719,545.95 |
| 减:库存股 | 50,012,725.12 | 50,012,725.12 | 50,012,725.12 | 50,012,725.12 |
| 其他综合收益 | -824,490.94 | -104,911.08 | 428,012.31 | 706,404.91 |
| 盈余公积 | 90,706,766.16 | 90,706,766.16 | 90,706,766.16 | 78,416,832.26 |
| 未分配利润 | 1,198,643,473.88 | 1,179,822,148.36 | 1,137,724,813.05 | 1,185,224,145.03 |
| 归属于母公司股东权益合计 | 2,706,348,262.93 | 2,688,246,517.27 | 2,646,682,105.35 | 2,682,169,896.03 |
| 少数股东权益 | -28,005,380.6 | -19,393,858.27 | -14,822,318.73 | -14,468,220.17 |
| 股东权益合计 | 2,678,342,882.33 | 2,668,852,659 | 2,631,859,786.62 | 2,667,701,675.86 |
| 负债和股东权益合计 | 6,131,729,147.06 | 6,025,914,332.42 | 5,774,681,479.45 | 5,671,665,281.42 |
| 公告日期 | 2026-08-25 | 2026-04-23 | 2026-03-18 | 2025-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |